NYSE:ABT - Abbott Laboratories
$83.36
 $-0.91
-1.08%
4:00PM EDT
2019-09-16
Abbott Laboratories is engaged in the discovery, development, manufacture and sale of a range of healthcare products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products and Vascular Products. Its Established Pharmaceutical Products include a range of branded generic pharmaceuticals manufactured around the world and marketed and sold outside the United States. Its Diagnostic Products include a range of diagnostic systems and tests. Its Nutritional Products include a range of pediatric and adult nutritional products. Its Company's Vascular Products include a range of coronary, endovascular, vessel closure and structural heart devices for the treatment of vascular disease. The Company, through St. Jude Medical, Inc., also offers products, such as rhythm management products, electrophysiology products, heart failure related products, vascular products, structural heart products and neuromodulation products. Read more at  reuters.com
sector:  health care
industry:  pharmaceuticals
the data below are updated and published after 9pm EDT each trading day
  ABT     avg for
industry  
  avg for
sector  
42 stocks weight:  207. 90   0. 00   0. 00  
42 stocks rank:  1. 45 K 1. 42 K 1. 30 K
# analyst opinions:  17. 00   10. 10   12. 97  
mean recommendation:  1. 70   2. 05   2. 07  

quick ratio:  0. 98   1. 41   1. 92  
current ratio:  1. 68   1. 90   2. 45  

ex-dividend date:     2019-07-11
dividend rate:  1. 28   1. 89   1. 62  
dividend yield:  1. 50 % 2. 59 % 1. 84 %
target price low:  90. 00   77. 19   109. 66  
target price avg:  94. 32   88. 73   131. 81  
target price high:  99. 00   99. 61   149. 31  
1-yr high:  88. 74   87. 26   134. 46  
last close:  83. 36   78. 22   117. 08  
50-day avg:  85. 34   78. 30   117. 12  
200-day avg:  78. 32   76. 62   113. 76  
1-yr low:  65. 56   65. 57   93. 76  
volume:  3. 42 M 4. 46 M 3. 04 M
50-day avg volume:  4. 53 M 6. 37 M 4. 09 M
200-day avg volume:  5. 63 M 7. 21 M 4. 63 M

1-day return:  3. 13 % 0. 09 % 0. 18 %
this week return:  -1. 08 % 0. 96 % 0. 77 %
12-wk return:  -0. 88 % 1. 13 % 2. 99 %
52-wk return:  25. 92 % 7. 06 % 4. 64 %

enterprise value (EV):  165. 84 B 173. 29 B 112. 94 B
market cap:  147. 33 B 2. 23 T 4. 95 T
EBITDA:  7. 53 B 11. 53 B 7. 74 B
enterprise multiple (EV/EBITDA):  22. 04   9. 24   10. 42  
enterprise/revenue (EV/R):  5. 36   9. 83   22. 18  
total revenue:  30. 93 B 33. 28 B 31. 64 B
total debt:  20. 07 B 20. 39 B 16. 97 B
debt/equity:  62. 92   162. 38   141. 17  
net income (common):  2. 87 B 5. 91 B 3. 90 B

shares outstanding:  1. 77 B 2. 24 B 1. 27 B
shares:  1. 75 B 2. 15 B 1. 22 B
shares short:  17. 05 M 19. 96 M 13. 52 M
shares short prior month:  16. 83 M 18. 23 M 12. 50 M
short ratio:  3. 26   3. 17   3. 68  
short % of float:  1. 00 % 1. 91 % 2. 78 %
total cash/share:  1. 91   4. 07   8. 82  
total cash:  3. 38 B 7. 33 B 5. 99 B
free cash flow:  3. 87 B 7. 42 B 4. 78 B
operating cash flow:  5. 72 B 8. 47 B 5. 77 B

book value:  17. 93   18. 11   26. 68  
price/book:  4. 65   8. 57   6. 12  
gross profits:  17. 92 B 67. 97 B 35. 94 B
operating margins:  14. 37 % -154. 44 % -202. 61 %
EBITDA margins:  24. 33 % 30. 48 % 24. 32 %
profit margins:  9. 36 % 20. 18 % 14. 56 %
gross margins:  58. 84 % 69. 58 % 58. 52 %

1-yr max volatility:  6. 10 % --- ---
1-yr mean volatility:  1. 09 % 0. 75 % 0. 86 %

1-yr EPS:  1. 63   2. 56   4. 02  
forward EPS:  3. 62   5. 09   6. 65  
P/E:  51. 27   23. 13   23. 91  
forward P/E:  23. 28   16. 04   12. 40  
PE/G:  4. 53   1. 07   -1. 71  
growth:  11. 33 % 46. 68 % 102. 21 %
earnings high:  0. 85   1. 22   1. 61  
earnings avg:  0. 84   1. 15   1. 50  
earnings low:  0. 83   1. 08   1. 39  
revenue high:  8. 16 B 9. 53 B 8. 82 B
revenue avg:  8. 11 B 9. 37 B 8. 66 B
revenue low:  8. 06 B 9. 19 B 8. 48 B
earnings growth:  37. 10 % 43. 47 % 138. 30 %
1-qtr earnings growth:  37. 20 % 94. 97 % 256. 65 %
return on assets:  4. 06 % 6. 90 % 5. 55 %
return on equity:  9. 21 % 28. 25 % 20. 45 %
revenue growth:  2. 70 % 24. 14 % 39. 99 %
revenue/share:  17. 54   15. 95   52. 14  

beta (1yr vs S&P500):  1. 03   0. 69   0. 87  
sharpe (1yr):  0. 97   0. 66   0. 48  

held % insiders:  0. 72 % 1. 95 % 3. 59 %
held % institutions:  76. 49 % 55. 03 % 67. 25 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-09-16 : ABT
.    145.469 =         145.469 :: --> INITIAL WEIGHT <--
.                               --> FUNDAMENTALS <--
.    x 2.772 =         403.206 :: P/E factor
.    x 0.956 =         385.375 :: PE/G factor
.    x 1.732 =         667.287 :: beta factor
.    x 0.995 =         664.239 :: sharpe factor
.     x 2.17 =        1441.598 :: current ratio factor
.    x 0.998 =        1438.557 :: quick ratio factor
.     x 1.18 =        1697.218 :: short ratio factor
.    x 1.062 =        1801.646 :: return on assets factor
.    x 1.127 =        2030.278 :: return on equity factor
.    x 1.308 =        2655.455 :: earnings growth factor
.    x 1.028 =        2731.066 :: revenue growth factor
.    x 1.572 =        4294.189 :: EV/R factor
.    x 1.057 =        4540.862 :: price-to-book factor
.    x 0.869 =        3946.134 :: enterprise-to-EBITDA factor
.    x 0.916 =        3615.751 :: enterprise-multiple vs industry factor
.    x 1.307 =        4724.642 :: debt-to-revenue factor
.    x 1.743 =        8236.537 :: debt-to-equity factor
.                               --> PERFORMANCE <--
.    x 2.783 =       22922.932 :: sector+industry 1-year gains factor
.    x 0.973 =        22292.97 :: industry 12-weeks return factor
.    x 1.308 =       29158.748 :: industry 2-weeks return factor
.    x 1.249 =       36421.297 :: company one-year gains+dividend factor
.    x 2.154 =       78436.343 :: company 13 weeks' performance factor
.    x 1.148 =       90036.555 :: 5-day avg > 200-day avg
.     x 1.09 =       98100.261 :: 50-day avg > 200-day avg
.    x 0.998 =       97953.017 :: "drift" penalty 4 days ago
.    x 0.997 =        97696.55 :: "drift" penalty 5 days ago
.    x 4.475 =      437234.547 :: overall "drift" factor
.    x 0.974 =      426062.921 :: largest single-day price delta factor
.    x 0.998 =      425406.791 :: volatility factor
.    x 0.998 =       424694.77 :: 42-day volatility factor
.    x 2.214 =      940364.996 :: inverse volume-to-price factor
.                               --> PROJECTIONS <--
.    x 1.358 =     1277386.449 :: forward EPS factor
.    x 1.485 =     1896830.175 :: forward P/E factor
.    x 1.191 =     2258955.544 :: industry recommendation factor
.    x 3.126 =     7060379.017 :: company recommendation factor
.    x 1.021 =     7211177.208 :: factor historical industry gain for week 37
.     x 1.35 =     9736310.636 :: target low factor
.    x 1.121 =     10913102.32 :: target mean factor
.    x 1.018 =    11111637.302 :: target high factor
.    x 10.48 =   116448001.331 :: spline projection factor
.                               --> FINAL ADJUSTMENTS <--
.  quad root =          103.88 :: reduced for readability
.   + 99.733 =         203.614 :: add/subtract for investor sentiment
.    + 4.291 =         207.904 :: earnings report in 29 days
.                               --> FINAL WEIGHT <--
.                    207.904 :: FINAL WEIGHT for NYSE:ABT


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org